Лечение ЗППП
42. Henry RE, WegmannJA HartleJE, Christopher GW Successful oral acyclovir desensitization Ann Allergy 1993 70386—8
43. Reiff-Eldndge RA, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries a pharmaceutical company commitment Am J Obstet Gynecol 2000, 182 159—63
44. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD, Jr Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes Obstet Gynecol 1996,87 69-73
45. Brocklehurst P, Kinghom G, Camey 0, et al A randomised placebo controlled trial of suppressive acylovir in late pregnancy in women with recurrent genital herpes infection Br J Obstet Gynaecol 1998 105 275-80
46. Thorpe ЕМ, Stamm WE, Hook EW, et al Chlamydial cervic itis and urethntis single dose treatment compared with doxycycline for seven days in community-based practices Gemtounn Med 1996 72 93-7
47. Stamm WE, Hicks CB, Martin DH, et al Azithromycin for empirical treatment of the nongonococcal urethntis syndrome in men a randomized double-blind study JAMA 1995 274 545-9
48. Adair CD, GunterM, Stovall TG, McElvoy G, VeilleJC. ErmentJM Chlamydia in pregnancy a randomized trial of azithromycin and enthromycin Obstet Gynecol 1998 91 165-8
49. Wehbeh НА, Ruggeino RM, Shakem S, Lopez G, All Y Single dose azithromycin for chlamydia in pregnant women J Reprod Med 1998 43 509-14
50. MoranJS, Levine WC Drugs of choice for the treatment of uncomplicated gonococcal infections Clin Infect Dis 1995,20(Suppl 1),S47—S65
51. Haimovici R, Rous'selTJ Treatment of gonococcal conjunctivitis with single-dose intramuscular ceftnaxone Am J Ophthalmol 1989 107 511
52. Hauth JC, Goldenberg RL. Andrews WW, DuBard MB, Copper RL Reduced incidence ofpreterm delivery with metromdazole and eryth-romycin in women with bacterial vaginosis N Engi J Med 1995 333 1732-6
53. Morales WJ Schorr S, Albntton J Effect of metromdazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis a placebo-controlled, double-blind study 'Am J Obstet Gynecol 1994 171 345-9
54. McDonald ИМ, O'LoughlinJA, Vigneswaran R, etal Impact of metromdazole thei ару on preterm birth in women with bacterial vaginosis flosa (Gardnerella vagmalis) a randomised, placebo controlled trial BrJObslet Gynaecol 1997 104 1391-7
55. Jack&on P, Rid ley WJ, Pattison NS Single dose metromdazole prophylaxis in gynaecological surgery NZ Med J 1979 89 243-5
56. WillisAT Metromdazole in the prevention and treatment of Bacleroides infections in gynaecological patients Lancet 1974,2 1540-3
57. PerssonE, BergstromM, LarswnPG, etal Infections after hysterec-tomv и prospective nationw ide Swedish Study Acta Obstetnca et Gynecologiaca Scandinavica 1996 75 757-61
58. Larsson PG, Platz-Chnstenven JJ, Forsum U, Pahlson С Clue cells in predicting infections after abdominal hysterectomy Obstet Gynecol 1991,77 450-2
59. Newton ER Pnhoda TJ. Gibbs RS A clinical and microbiologic analysis of risk factors for puerperal endotnetntis Obstet Gynecol 1990 75 402-6
60. Soper DE, Bump RC, Hurt WG Bacterial vaginosis and Inc ho manias i1, agimtiv are rifk factors fui cuff ceilulitis after abdominal h steiectomy Am] Obstet Gynecol /990,163 1016-21
61. Watts DH Krohn MA, Hillier SL, Eschenbach DA Bacterial vaginosis ач a risk factor for post-f ечагеап endometnti ? Obstet Gynecol 1990 75 52-8
62. Sihcr HM, SperiingRS Sf Glair PJ, Gibbs RS Evidence relating bacterial vaginow ю inti aammotic infection Am J Obstet Gynecol 1989 161 808-12
63. B/ornerem A, Aghajam E MaltauJM.MoiH Occurrence of bacterial vagino4is among abortion seekers Tidssknft for Den Norske Laegeforemng 1997, i 17 1282-4
64. Hamark В, Foreman L Postabortal endometntis in chlamydia-negative women-association with preoperative clinical signs of infection Gvnecol Obstet Invest 1991 31 102-5
65. Lars чоп PG, Bergman В fo! sum U, Platz-Chnstensen JJ, Pahlson С Mobiluncus and clue cells as predictors ofPID after first-trimester abortion Acta Obstetnca ei Gvnecologica Scandinavica 1989 68 217-20
66. Hillier SL, Marcus J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA A case-control study of chonoammomc infection and histologic chorioamniomti4 in prematurity New Engi J Med 1998 319 972-8
67. Livengood СН, Ш, Super DE, Sheehan KL, et al Companson of once-daily and twice-daily dosing ofO 75% metromdazole gel in the treatment of bacterial vaginosis Sex Transm Dis 1999,26 137—42
68. Sobel J Peipert JF, McGregor JA, et al Efficacy of clindamycin vaginal ovule vs clindamycin vaginal cream in bacterial vaginosis Infect Dis Obfitet Gynecol 2002 (in press}
69. Moi H, Erkkola R, Jerve F, et al Should male consorts of women with bacterial vaginosiv be treated9 Gemtounn Med 1989 65 263—8
70. Colli E Landoni M, Parazzim F, et al Treatment of male partners and recurrence of bacterial vaginosis a randomised trial Gemtounn Med 1997 73 267-70
71. VejtorpM.BollcrupAC.VejtorpL, etal Bacterial vaginosis adouble-blind randomized trial of the effect of treatment of the sexual partner BrJ Obstet Gynaecol 1988 95 920-6
72. McGregor JA, French Jl, Jones W, et al Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase andsialidase results of a controlled trial of topical clindamycin cream Am J Obstet Gynecol 1994 170 1048-59
73. JoesoefMR, Hilher SL, Wihyosastro G, et al Intravagmal chndamycin treatment for bacterial vaginosis effects on preterm delivery and low birth weight Am J Obstet Gynecol 1995 173 1527-31
74. Vermeulen GM, Bruinse HW Prophylactic administration of chndamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk a randomised placebo-controlled double-blind ti lal Br J Obstet Gynaecol 1999 106 652-7
75. Caro-Paton T, Carvajal A Martin de Diego I Maitin-Anas LH, Alvarez Requejo A Is metromdazole teratogemc/> A meta-analysis BrJClin Pharmacol 1997 44 179-82
76. Burtin P, Taddio A, Anburnu О Einarwn TR Koren G Safety of metromdazole in pregnancy a meta-analysis Am J Obstet Gynecol 1995,172 525-9
77. Piper JM, Mitchel Ef, Ray WA Prenatal use of metromdazole and birth defects no association Obstet Gynecol 1993,82 348-52
78. Carey JC, KlebanoffMA, Hauth JC et al Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis New Engi J Med 2000 342 534-40
79. Hay PE, Ugwumadii ANN, Jeffrey I, Manvonda JT Oral chndamycin prevent'! spontaneous pretei т birth and mid trimester miscarriage in pregnant women with bacterial vaginosis Int J STD AIDS 2001.12(Suppl2) 70-1
80. PearlmanMD, Yashaf C, Ernst S, Solomon W An incremental dosing protocol for women with severe vaginal tnchomoniasis and adverse reactions to metromdazole Am J Obstet Gynecol 1996, 174 934-6
81. KlebanoffMA, Caiev JC, Hauth JC et al Failure of metromdazole to prevent preterm delivery among pregnant women with asymptomatic Tnchomonas vagmalis infection New Engi J Med 2001 345 487-93
